av/dr-reddys--big.svg

NYSE:RDY

Dr. Reddy's Laboratories Limited

  • Stock

USD

Last Close

1,183.90

02/05 08:51

Market Cap

1.10T

Beta: 0.24

Volume Today

850.23K

Avg: 213.67K

PE Ratio

19.34

PFCF: 35.19

Dividend Yield

0.02%

Payout:12.73%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
average inventory
24.76B
-
25.55B
3.20%
27.05B
5.87%
28.81B
6.49%
31.33B
8.76%
34.32B
9.54%
40.24B
17.24%
48.15B
19.66%
49.78B
3.38%
56.11B
12.72%
67.32B
19.97%
average payables
10.58B
-
11.48B
8.49%
12.86B
12.01%
14.73B
14.59%
15.30B
3.85%
12.65B
17.34%
16.33B
29.11%
23.74B
45.40%
24.13B
1.62%
19.70B
18.34%
28.54B
44.83%
average receivables
46.37B
-
50.34B
8.57%
49.71B
1.26%
47.17B
5.11%
44.23B
6.23%
52.51B
18.73%
57.07B
8.68%
61.22B
7.27%
71.27B
16.42%
76.39B
7.19%
85.36B
11.74%
book value per share
653.51
-
752.49
15.15%
744.34
1.08%
762.52
2.44%
844.99
10.82%
934.92
10.64%
1.06K
12.85%
1.15K
8.86%
1.40K
22.11%
337.21
75.96%
2.02K
500.35%
capex per share
-89.99
-
-87.22
3.08%
-245.93
181.97%
-66.59
72.92%
-45.15
32.19%
-36.89
18.30%
-75.74
105.33%
-114.83
51.62%
-113.62
1.06%
32.98
129.02%
165.14
400.80%
capex to depreciation
-1.89
-
-1.45
23.31%
-3.63
150.43%
-0.94
74.05%
-0.61
34.84%
-0.49
20.21%
-0.98
100.21%
-1.61
64.12%
-1.51
6.34%
1.85
222.51%
1.61
12.78%
capex to operating cash flow
-0.61
-
-0.36
41.10%
-1.91
428.26%
-0.61
67.85%
-0.26
57.39%
-0.20
21.48%
-0.35
71.69%
-0.68
92.63%
-0.32
52.72%
0.60
288.46%
0.59
1.90%
capex to revenue
-0.10
-
-0.10
7.04%
-0.29
202.72%
-0.08
73.29%
-0.05
37.38%
-0.04
28.07%
-0.07
89.04%
-0.09
34.20%
-0.08
13.65%
0.10
228.10%
0.08
14.03%
cash per share
433.98
-
439.70
1.32%
194.46
55.77%
126.43
34.98%
149.21
18.02%
155.27
4.06%
208.47
34.26%
267.45
28.29%
402.02
50.32%
97.92
75.64%
347.70
255.07%
days of inventory on hand
148.41
-
149.55
0.77%
166.73
11.49%
161.55
3.11%
174.04
7.74%
158.82
8.75%
191.30
20.46%
184.71
3.45%
414.02
124.15%
200.74
51.52%
192.04
4.33%
days payables outstanding
61.97
-
71.92
16.05%
78.41
9.04%
89.15
13.68%
75.43
15.39%
48.66
35.48%
92.32
89.71%
92.83
0.55%
192.97
107.88%
68.06
64.73%
95.97
41.01%
days sales outstanding
124.17
-
118.60
4.49%
127.40
7.43%
116.12
8.86%
102.65
11.60%
129.10
25.76%
100.78
21.93%
119.26
18.33%
107.60
9.77%
104.99
2.43%
101.38
3.43%
debt to assets
0.22
-
0.16
27.11%
0.22
38.64%
0.22
0.47%
0.17
24.26%
0.10
44.10%
0.11
19.95%
0.11
0.06%
0.04
63.42%
0.04
2.18%
0.09
122.48%
debt to equity
0.39
-
0.26
32.60%
0.40
51.84%
0.40
1.14%
0.27
31.73%
0.14
47.91%
0.17
21.46%
0.18
2.56%
0.06
67.43%
0.06
1.80%
0.14
138.18%
dividend yield
0.01
-
0.01
31.39%
0.01
2.58%
0.01
46.09%
0.01
23.55%
0.01
12.29%
0.01
26.85%
0.01
5.08%
0.01
11.49%
0.01
1.46%
0.03
443.12%
earnings yield
0.04
-
0.04
3.58%
0.03
29.02%
0.03
1.05%
0.04
46.16%
0.04
7.02%
0.03
32.16%
0.03
29.37%
0.06
77.55%
0.05
8.83%
0.29
450.35%
enterprise value
597.66B
-
511.20B
14.47%
469.73B
8.11%
401.67B
14.49%
499.86B
24.44%
537.39B
7.51%
764.43B
42.25%
731.53B
4.30%
775.22B
5.97%
1.05T
35.82%
224.01B
78.73%
enterprise value over ebitda
22.74
-
17.26
24.09%
34.80
101.63%
33.71
3.14%
21.17
37.18%
10.85
48.76%
15.65
44.20%
13.90
11.18%
7.13
48.72%
11.93
67.38%
2.45
79.50%
ev to operating cash flow
23.87
-
12.39
48.09%
21.83
76.17%
22.28
2.04%
17.41
21.84%
18.01
3.41%
21.41
18.89%
26.03
21.55%
13.17
49.41%
23.18
76.00%
4.82
79.18%
ev to sales
4.03
-
3.30
18.07%
3.34
0.96%
2.83
15.22%
3.25
14.88%
3.08
5.27%
4.03
30.91%
3.41
15.31%
3.15
7.60%
3.77
19.63%
0.69
81.76%
free cash flow per share
56.99
-
154.63
171.34%
-116.84
175.56%
42.12
136.05%
127.85
203.52%
143.12
11.94%
139.54
2.50%
54.61
60.86%
240.97
341.25%
21.63
91.02%
113.63
425.25%
free cash flow yield
0.02
-
0.05
211.88%
-0.04
187.12%
0.02
144.51%
0.05
131.55%
0.05
0.25%
0.03
32.62%
0.01
58.85%
0.05
310.01%
0.02
66.80%
0.10
469.86%
graham net net
240.90
-
270.69
12.37%
-73.47
127.14%
-179.34
144.10%
-67.70
62.25%
74.41
209.92%
36.53
50.91%
97.76
167.61%
334.01
241.66%
79.93
76.07%
32.68
59.12%
graham number
1.38K
-
1.41K
1.86%
1.10K
21.96%
1.01K
8.43%
1.47K
45.71%
1.57K
7.18%
1.66K
5.26%
1.92K
15.74%
2.93K
52.75%
712.61
75.65%
3.91K
448.75%
income quality
1.13
-
2.06
82.60%
1.79
13.30%
1.84
2.89%
1.53
16.93%
1.53
0.21%
1.86
21.82%
1.19
36.03%
0.97
18.39%
0.82
16.18%
0.82
0.64%
intangibles to total assets
0.08
-
0.12
40.68%
0.22
86.58%
0.22
2.70%
0.21
0.62%
0.14
36.35%
0.15
11.14%
0.11
29.54%
0.11
5.04%
0.11
5.17%
0.22
107.20%
interest coverage
24.07
-
35.86
48.97%
21.29
40.63%
15.12
28.97%
17.96
18.76%
37.70
109.88%
37.18
1.38%
42.61
14.61%
67.42
58.25%
39.58
41.29%
interest debt per share
259.63
-
201.35
22.45%
298.95
48.47%
310.54
3.88%
238.34
23.25%
139.25
41.57%
188.60
35.43%
209.80
11.24%
89.74
57.23%
21.92
75.58%
280.80
1,181.22%
inventory turnover
2.46
-
2.44
0.76%
2.19
10.31%
2.26
3.21%
2.10
7.18%
2.30
9.59%
1.91
16.98%
1.98
3.57%
0.88
55.39%
1.82
106.25%
1.90
4.53%
invested capital
0.39
-
0.26
32.60%
0.40
51.84%
0.40
1.14%
0.27
31.73%
0.14
47.91%
0.17
21.46%
0.18
2.56%
0.06
67.43%
270.10B
466,862,797,654,294.31%
326.09B
20.73%
market cap
594.18B
-
517.65B
12.88%
438.68B
15.26%
353.60B
19.39%
463.70B
31.14%
517.35B
11.57%
748.95B
44.77%
712.54B
4.86%
767.53B
7.72%
1.04T
35.50%
191.89B
81.55%
net current asset value
36.38B
-
40.37B
10.98%
4.60B
88.61%
10.50B
128.38%
29.27B
178.74%
53.12B
81.47%
57.74B
8.70%
74.98B
29.86%
114.27B
52.40%
141.08B
23.47%
94.29B
33.17%
net debt to ebitda
0.13
-
-0.22
264.66%
2.30
1,157.62%
4.03
75.38%
1.53
62.04%
0.40
73.57%
0.32
21.74%
0.36
13.88%
0.07
80.40%
0.15
106.85%
0.35
139.62%
net income per share
130.22
-
117.35
9.89%
72.24
38.44%
59.13
18.15%
113.28
91.59%
117.62
3.83%
115.46
1.83%
142.08
23.05%
271.47
91.07%
66.93
75.35%
339.51
407.26%
operating cash flow per share
146.98
-
241.85
64.55%
129.09
46.62%
108.71
15.79%
173.00
59.14%
180.01
4.05%
215.28
19.59%
169.45
21.29%
354.59
109.26%
54.61
84.60%
278.77
410.48%
payables turnover
5.89
-
5.08
13.83%
4.65
8.29%
4.09
12.04%
4.84
18.18%
7.50
55.00%
3.95
47.29%
3.93
0.54%
1.89
51.90%
5.36
183.53%
3.80
29.08%
receivables turnover
2.94
-
3.08
4.70%
2.86
6.91%
3.14
9.72%
3.56
13.12%
2.83
20.48%
3.62
28.09%
3.06
15.49%
3.39
10.83%
3.48
2.49%
3.60
3.56%
research and ddevelopement to revenue
0.12
-
0.12
2.10%
0.14
20.45%
0.13
7.38%
0.10
21.12%
0.09
13.00%
0.09
1.22%
0.08
6.47%
0.08
3.33%
0.08
3.95%
0.08
2.65%
return on tangible assets
0.12
-
0.11
12.07%
0.07
35.67%
0.06
21.24%
0.11
91.49%
0.10
8.38%
0.09
12.55%
0.09
4.63%
0.16
76.79%
0.16
2.26%
0.15
8.51%
revenue per share
870.09
-
907.12
4.26%
844.94
6.85%
856.39
1.35%
927.28
8.28%
1.05K
13.58%
1.14K
8.62%
1.29K
12.98%
1.48K
14.58%
335.55
77.34%
1.95K
482.52%
roe
0.20
-
0.16
21.74%
0.10
37.76%
0.08
20.10%
0.13
72.89%
0.13
6.16%
0.11
13.01%
0.12
13.03%
0.19
56.48%
0.20
2.54%
0.17
14.55%
roic
0.13
-
0.13
0.70%
0.06
52.47%
0.05
28.17%
0.10
113.02%
0.22
129.45%
0.12
47.83%
0.13
12.13%
0.29
121.16%
0.18
39.04%
0.13
24.48%
sales general and administrative to revenue
0.19
-
shareholders equity per share
653.51
-
752.49
15.15%
744.34
1.08%
762.52
2.44%
844.99
10.82%
934.92
10.64%
1.06K
12.85%
1.15K
8.86%
1.40K
22.11%
337.21
75.96%
2.00K
493.63%
stock based compensation to revenue
0.00
-
0.00
9.41%
0.00
7.16%
0.00
13.09%
0.00
20.90%
0.00
18.02%
0.00
3.16%
0.00
10.29%
0.00
41.53%
0.00
9.70%
0.00
10.66%
tangible asset value
94.87B
-
103.69B
9.30%
75.37B
27.32%
77.85B
3.29%
91.93B
18.08%
123.33B
34.16%
134.76B
9.27%
158.86B
17.88%
196.66B
23.79%
239.35B
21.70%
228.55B
4.51%
tangible book value per share
557.04
-
607.99
9.15%
452.25
25.62%
469.41
3.80%
554.06
18.03%
743.99
34.28%
812.60
9.22%
957.68
17.85%
1.18K
23.68%
287.69
75.71%
1.37K
377.02%
working capital
55.84B
-
55.04B
1.43%
15.38B
72.07%
39.95B
159.86%
54.80B
37.16%
57.56B
5.03%
66.78B
16.02%
83.26B
24.69%
118.53B
42.36%
152.01B
28.24%
119.72B
21.24%

All numbers in USD (except ratios and percentages)